Search Details

Word: breast (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

ALCOHOL Cirrhosis of the liver isn't the only damage alcohol does: it can also lead to cancers of the mouth, larynx and esophagus. The report links drinking with liver and breast cancer as well...

Author: /time Magazine | Title: What's Off, What's On | 5/29/2000 | See Source »

TAMOXIFEN This one, the government concedes, is tricky. Tamoxifen is considered an effective drug for staving off breast cancer in high-risk women and preventing a recurrence in women who already have the disease. But it's also known to increase the risk of uterine cancer. The Food and Drug Administration has nonetheless determined that the benefits of the drug outweigh the risks, and HHS scientists are concerned that the new report could discourage some women who could be helped by tamoxifen from taking...

Author: /time Magazine | Title: What's Off, What's On | 5/29/2000 | See Source »

FLASH! Tamoxifen may help prevent breast cancer, but one of the most common and intrusive side effects is hot flashes, even among women who've already gone through menopause. Relief may be in sight. A small study suggests that women who take the high-blood-pressure drug clonidine experience about one-third fewer flashes...

Author: /time Magazine | Title: Your Health: May 29, 2000 | 5/29/2000 | See Source »

...water and fishing grounds--which some believe is why the cay has a 27% higher cancer rate than the main island. And because Vieques has some of the Caribbean's most exquisite beaches, locals complain that the Navy exercises have blighted tourism. Julio Rosa's sister Carmen, lost a breast to cancer a decade ago. (She lived a few miles downwind from the explosions.) He looks out from the helm of the Garata and says simply, "We have real-life issues here...

Author: /time Magazine | Title: The Guns of May, the Sounds of Countrymen | 5/15/2000 | See Source »

DRUG WARNING Since its debut in 1998, Herceptin has stemmed the growth of breast cancer in tens of thousands of women. But now its maker, Genentech, is alerting doctors to possible adverse reactions and even death in a small percentage of patients who have a history of lung problems and did not respond to chemotherapy. A new label in the works will help doctors select the patients best suited for the gene-spliced drug. --By Janice M. Horowitz...

Author: /time Magazine | Title: Your Health: May 15, 2000 | 5/15/2000 | See Source »

Previous | 265 | 266 | 267 | 268 | 269 | 270 | 271 | 272 | 273 | 274 | 275 | 276 | 277 | 278 | 279 | 280 | 281 | 282 | 283 | 284 | 285 | Next